Our MaxCyte scientist, Lauren Unsworth, presents her poster from the 2024 American Society of Gene and Cell Therapy annual meeting. In this study, we optimized conditions for electroporating primary NK cells with the GMP-compliant MaxCyte ExPERT GTx electroporation platform, with specific focus on maximizing cell viability, cell recovery, transfection efficiency, cell expansion and functionality.